Guoli Li

机构：Hangzhou Normal University, Tianjin Medical University Cancer Institute and Hospital, Lanzhou Jiaotong University, Wuhan University, Affiliated Hospital of Hangzhou Normal University, Zhongnan Hospital of Wuhan University · ORCID：0009-0002-7660-6386

发表论文 81 篇 · 总被引 1333 次 · h-index 21

代表论文

• NNMT/1‐MNA Promote Cell‐Cycle Progression of Breast Cancer by Targeting UBC12/Cullin‐1‐Mediated Degradation of P27 Proteins (2023 · Advanced Science · 被引 25)
• The RNA ‐binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA (2024 · Cancer Medicine · 被引 11)
• CD169+ macrophages identify and eliminate tumor cells in colorectal cancer through CD169/CD43 interaction and FasL-driven apoptosis (2025 · Cell Reports · 被引 10)
• Uncovering the whole genome silencers of human cells via Ss-STARR-seq (2025 · Nature Communications · 被引 10)
• Research Progress on Plant‐Derived Cardenolides (2010–2023) (2024 · Chemistry & Biodiversity · 被引 6)
• Bisabolane Sesquiterpenes with Anti-Chlamydial Activity Isolated from Ligularia narynensis (2025 · International Journal of Molecular Sciences · 被引 5)